Back to search
Polypharmacy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Polypharmacy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Polypharmacy trials you may qualify forThe purpose of this study is to evaluate the impact of pharmacist-led medication reviews and deprescribing or de-escalation interventions on reducing the number…
The overarching goal of this study is to pilot an intervention in which older adults with mild cognitive impairment and dementia and the older adult's care part…
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for pati…
The purpose of this study is to evaluate whether an intervention called Pediatric Medication Therapy Management (pMTM) improves the identification and managemen…
It is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effect…
The aim of this study is to evaluate the impact of an enhanced collaboration between a hospital pharmacist and a community pharmacist during hospital discharge.…
Elders living with multiple chronic conditions often take many drugs (polypharmacy); some of the drugs may not benefit them or may be harmful. The Canadian Inst…
High-risk polypharmacy is common among older adults in the United States, is particularly dangerous for individuals with dementia or cognitive impairment, and i…